Relative risks of HPA axis effects for commonly prescribed corticosteroid dose regimens Source: Eur Respir J 2004; 24: Suppl. 48, 620s Year: 2004
Is high-dose glucocorticoid beneficial in COVID-19? Source: Eur Respir J, 57 (4) 2100065; 10.1183/13993003.00065-2021 Year: 2021
Morning cortizolemia and bone status during long term therapy with inhaled steroids in children Source: Annual Congress 2007 - Anti-inflammatory therapy for childhood asthma Year: 2007
Mometasone furoate reduces oral corticosteroid requirements and permits recovery of hypothalamic-pituitary-adrenal axis function in patients with severe persistent asthma Source: Eur Respir J 2002; 20: Suppl. 38, 407s Year: 2002
Does a short course of oral glucocorticoids interfere with immune response in children with acute asthma? Source: Eur Respir J 2006; 28: Suppl. 50, 709s Year: 2006
Salivary cortisol for assessment of hypothalamic-pituitary-adrenal (HPA) axis function in asthmatic children on inhaled corticosteroids (ICS) Source: Annual Congress 2011 - Treating childhood asthma Year: 2011
Changes in glucose metabolism during treatment with high doses of inhaled corticosteroids Source: Eur Respir J 2004; 24: Suppl. 48, 502s Year: 2004
Does short-term treatment intensification influence long-term treatment effects on health status in COPD? Source: Eur Respir J 2005; 26: Suppl. 49, 293s Year: 2005
Effect of discontinuation and readministration of inhaled human insulin on pulmonary safety in adult diabetes patients Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology Year: 2007
Long-term oral corticosteroid-sparing effects of anti-IL5/anti-IL5 receptor treatment. Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies Year: 2021
New serum measures of the insulin like growth factor axis in children with asthma treated with exogenous glucocorticoids Source: Eur Respir J 2006; 28: Suppl. 50, 852s Year: 2006
Does the treatment with inhaled steroids or long acting β-2-agonists prevent LRTIs? Source: Annual Congress 2009 - PG1 EU GRACE Network Full-day Course: vaccination and preventive measures for LRTIs in the community: what’s new? Year: 2009
Muscle regrowth in COPD patients induced by anabolic steroids is amplified by systemic glucocorticoids (GC): A potentiating interaction between GC and IGF-1? Source: Annual Congress 2011 - Challenges in chronic disease management: helping individuals with chronic lung disease remain stable Year: 2011
Long-term treatment with ciclesonide once daily has no effect on growth velocity, skeletal maturity and HPA-axis function in children with mild persistent asthma Source: Eur Respir J 2006; 28: Suppl. 50, 711s Year: 2006
Effect of augmentation therapy on immune function of patients with severe Alpha1-antitrypsin deficiency Source: Annual Congress 2012 - COPD treatments: efficacy and safety Year: 2012
Effect of oral N-acetylcysteine treatment on systemic inflammatory status in COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 716s Year: 2005
The effects of hormone replacement therapy on pulmonary function in postmenopausal women Source: Eur Respir J 2004; 24: Suppl. 48, 574s Year: 2004
Effect of dupilumab on oral corticosteroid use in severe asthma patients with improving lung function Source: Virtual Congress 2020 – Recent innovations regarding the mechanisms and treatments of asthma Year: 2020
High dose short course of inhaled corticosteroid administration may prevent home oxygen therapy in neonatal chronic lung disease Source: Eur Respir J 2003; 22: Suppl. 45, 140s Year: 2003
Biomarker-high patients and steroid responsiveness Source: International Congress 2018 – PG17 Asthma phenotyping Year: 2018